Review article: the role of butyrate on colonic function

Background  Butyrate, a short‐chain fatty acid, is a main end‐product of intestinal microbial fermentation of mainly dietary fibre. Butyrate is an important energy source for intestinal epithelial cells and plays a role in the maintenance of colonic homeostasis.

[1]  R. Whitehead,et al.  Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[2]  G. Macfarlane,et al.  Comparison of fermentation reactions in different regions of the human colon. , 1992, The Journal of applied bacteriology.

[3]  E. Sausville,et al.  Phase I Study of the Orally Administered Butyrate Prodrug, Tributyrin, in Patients with Solid Tumors1 , 2022 .

[4]  I. Holzman,et al.  Variable Effects of Short Chain Fatty Acids and Lactic Acid in Inducing Intestinal Mucosal Injury in Newborn Rats , 2002, Journal of pediatric gastroenterology and nutrition.

[5]  Johan Auwerx,et al.  Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis , 2003 .

[6]  J. Cuber,et al.  Luminal glucagon-like peptide-1(7-36) amide-releasing factors in the isolated vascularly perfused rat colon. , 1995, The Journal of endocrinology.

[7]  S. Loitsch,et al.  PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. , 2000, Biochemical and biophysical research communications.

[8]  Lawrence A Leiter,et al.  Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. , 1997, Metabolism: clinical and experimental.

[9]  M. Schwab,et al.  PPARγ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2 , 2006, Apoptosis.

[10]  I. Björck,et al.  Increasing Fecal Butyrate in Ulcerative Colitis Patients by Diet: Controlled Pilot Study , 2003, Inflammatory bowel diseases.

[11]  B. Deplancke,et al.  Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. , 2001, The American journal of clinical nutrition.

[12]  Yoshio Araki,et al.  Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. , 2004, International journal of molecular medicine.

[13]  S. Shirazi-Beechey,et al.  Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy , 2002, British Journal of Cancer.

[14]  F. Recillas-Targa,et al.  Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines. , 2005, Journal of experimental & clinical cancer research : CR.

[15]  H. Blottière,et al.  Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[16]  L. Sobin,et al.  Colon and Rectum , 1998 .

[17]  P. Gibson,et al.  Combination therapy of hepatitis B , 2000, Gut.

[18]  D. Meyer,et al.  Nondigestible Oligo- and Polysaccharides (Dietary Fiber): Their Physiology and Role in Human Health and Food. , 2002, Comprehensive reviews in food science and food safety.

[19]  R. van der Meer,et al.  Nutrient Physiology, Metabolism, and Nutrient-nutrient Interactions Dietary Fructooligosaccharides Affect Intestinal Barrier Function in Healthy Men , 2022 .

[20]  A. Hopkins,et al.  Modulation of tight junction structure and function by cytokines. , 2000, Advanced drug delivery reviews.

[21]  A. Senagore,et al.  Short-chain fatty acid enemas: A cost-effective alternative in the treatment of nonspecific proctosigmoiditis , 1992, Diseases of the colon and rectum.

[22]  H. Furuya,et al.  Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. , 2005, The Journal of nutrition.

[23]  R. Place,et al.  HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα , 2005 .

[24]  L. Thim.  Trefoil peptides: from structure to function , 1997, Cellular and Molecular Life Sciences CMLS.

[25]  L. Augenlicht,et al.  Essential Role of the JAK/STAT1 Signaling Pathway in the Expression of Inducible Nitric-oxide Synthase in Intestinal Epithelial Cells and Its Regulation by Butyrate* , 2007, Journal of Biological Chemistry.

[26]  E. Heineman,et al.  Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients With an Ileal Pouch-Anal Anastomosis , 2002, Diseases of the colon and rectum.

[27]  R. Claus,et al.  Increased butyrate formation in the pig colon by feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the stem cell compartment. , 2003, Metabolism: clinical and experimental.

[28]  B. Xia,et al.  Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats , 2006, Postgraduate Medical Journal.

[29]  D. Frings,et al.  Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1α nuclear translocation , 2003 .

[30]  C. Edwards,et al.  Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? , 2006, The British journal of nutrition.

[31]  P. Mortensen,et al.  Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. , 1991, Gut.

[32]  D. Arango,et al.  Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Bingham,et al.  Starch intake and colorectal cancer risk: an international comparison. , 1994, British Journal of Cancer.

[34]  J. Holst,et al.  Colonic fermentation and proximal gastric tone in humans. , 1996, Gastroenterology.

[35]  M. Millecamps,et al.  Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats , 2002, Pain.

[36]  L. Yin,et al.  The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. , 2000, Gastroenterology.

[37]  Young-In Kim,et al.  AGA technical review: impact of dietary fiber on colon cancer occurrence. , 2000, Gastroenterology.

[38]  P. Gibson,et al.  Effect of topical butyrate on rectal epithelial kinetics and mucosal enzyme activities. , 1998, Clinical science.

[39]  P. Nanni,et al.  A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. , 2007, World journal of gastroenterology.

[40]  R. Fabiani,et al.  Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. , 2001, Carcinogenesis.

[41]  W. Peters,et al.  Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. , 2003, Carcinogenesis.

[42]  A. Keshavarzian,et al.  Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. , 2008, Nutrition reviews.

[43]  K. Ushida,et al.  Dietary sodium gluconate protects rats from large bowel cancer by stimulating butyrate production. , 2004, The Journal of nutrition.

[44]  K. Matsumoto,et al.  Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice. , 1999, Cancer letters.

[45]  J. Holst,et al.  Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. , 2003, Gastroenterology.

[46]  J. Wehkamp,et al.  A New Look at Crohn's Disease , 2006, Annals of the New York Academy of Sciences.

[47]  P. Vernia,et al.  Organic anions and the diarrhea of inflammatory bowel disease , 1988, Digestive Diseases and Sciences.

[48]  M. Chapman,et al.  In vivo colonic butyrate metabolism and colonic permeability in extensive ulcerative colitis. , 1998, Gastroenterology.

[49]  V. Dalal,et al.  Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. , 1996, Gut.

[50]  K. Barrett.  A new twist on trefoils. Focus on “TFF3 modulates NF-κB and a novel regulatory molecule of NF-κB in intestinal epithelial cells via a mechanism distinct from TNF-α” , 2005 .

[51]  V. Ganapathy,et al.  SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. , 2006, Life sciences.

[52]  W. Babidge,et al.  Colonic Luminal Hydrogen Sulfide Is Not Elevated in Ulcerative Colitis , 2004, Digestive Diseases and Sciences.

[53]  J. Slavin,et al.  Molecular weight of guar gum affects short-chain fatty acid profile in model intestinal fermentation. , 2006, Molecular nutrition & food research.

[54]  M. Comalada,et al.  The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype , 2006, Journal of Cancer Research and Clinical Oncology.

[55]  D. Topping,et al.  Volatile fatty acids in the human intestine: Studies in surgical patients , 1985 .

[56]  A. Venkatraman,et al.  Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[57]  T. Iwanaga,et al.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine , 2006, Cell and Tissue Research.

[58]  G. Rechkemmer,et al.  Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. , 1999, Carcinogenesis.

[59]  C. Jayawickreme,et al.  The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. , 2006, Biochemical Society transactions.

[60]  P. Gibson,et al.  Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro. , 1994, Gastroenterology.

[61]  M. Schwab,et al.  Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling. , 2007, Molecular immunology.

[62]  J. Mariadason,et al.  Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. , 1997, The American journal of physiology.

[63]  V. Stigliano,et al.  Topical butyrate for acute radiation proctitis: randomised, crossover trial , 2000, The Lancet.

[64]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[65]  P. Gibson,et al.  Short-chain fatty acids promote the migration of colonic epithelial cells in vitro. , 1997, Gastroenterology.

[66]  S. Asai,et al.  Usefulness of rectally administering [1-13C]-butyrate for breath test in patients with active and quiescent ulcerative colitis , 2007, Scandinavian journal of gastroenterology.

[67]  S. Truelove,et al.  Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. , 1982, Journal of clinical pathology.

[68]  D. Burkitt.  Epidemiology of cancer of the colon and rectum , 1971, Cancer.

[69]  H. Lührs,et al.  Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis , 2002, Scandinavian journal of gastroenterology.

[70]  S. Gendler,et al.  Epithelial mucin genes. , 1995, Annual review of physiology.

[71]  L. Augenlicht,et al.  Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. , 2003, Molecular cancer research : MCR.

[72]  M. Langman,et al.  Impaired Detoxication of Hydrogen Sulfide in Ulcerative Colitis? , 2007, Digestive Diseases and Sciences.

[73]  A. Rademaker,et al.  Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. , 1997, Gut.

[74]  P. Mortensen,et al.  Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Plantago ovata seeds). , 1996, Scandinavian journal of gastroenterology.

[75]  W. Scheppach,et al.  The butyrate story: old wine in new bottles? , 2004, Current opinion in clinical nutrition and metabolic care.

[76]  Paolo Vineis,et al.  Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study , 2003, The Lancet.

[77]  W. Babidge,et al.  Colonic Sulfide in Pathogenesis and Treatment of Ulcerative Colitis , 1997, Digestive Diseases and Sciences.

[78]  E. Chang,et al.  Short-chain fatty acids induce intestinal epithelial heat shock protein 25 expression in rats and IEC 18 cells. , 2001, Gastroenterology.

[79]  S. V. van Deventer,et al.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. , 2003, Gut.

[80]  F. González,et al.  Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. , 1998, JPEN. Journal of parenteral and enteral nutrition.

[81]  F. Sinicrope,et al.  Evaluation of short-chain fatty acid enemas: treatment of radiation proctitis. , 1996, The American journal of gastroenterology.

[82]  D. Frings,et al.  Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1alpha nuclear translocation. , 2003, Biochemical and biophysical research communications.

[83]  J. Tjandra,et al.  The Influence of Specific Luminal Factors on the Colonic Epithelium: High-Dose Butyrate and Physical Changes Suppress Early Carcinogenic Events in Rats , 2005, Diseases of the colon and rectum.

[84]  C. M. Wood,et al.  Treatment of diversion colitis with short-chain-fatty acid irrigation. , 1989, The New England journal of medicine.

[85]  E. Skrzydlewska,et al.  Lipid peroxidation and antioxidant status in colorectal cancer. , 2005, World journal of gastroenterology.

[86]  I. Johnson,et al.  Dietary lactitol fermentation increases circulating peptide YY and glucagon-like peptide-1 in rats and humans. , 2005, Nutrition.

[87]  J. Alverdy,et al.  Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[88]  J. Auwerx,et al.  Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. , 2003, Gastroenterology.

[89]  E. N. Bergman.  Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. , 1990, Physiological reviews.

[90]  J. Cuber,et al.  Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. , 1996, The Journal of endocrinology.

[91]  C. Dempfle,et al.  Histological changes in the colonic mucosa following irrigation with short‐chain fatty acids , 1997, European journal of gastroenterology & hepatology.

[92]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.

[93]  A. Gostner,et al.  Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. , 1998, The American journal of clinical nutrition.

[94]  J. Mariadason,et al.  Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation , 2003, Oncogene.

[95]  Huawei Zeng,et al.  Prolonged butyrate treatment inhibits the migration and invasion potential of HT1080 tumor cells. , 2005, The Journal of nutrition.

[96]  O. Velazquez,et al.  Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. , 1997, Advances in experimental medicine and biology.

[97]  N. Blin,et al.  Tumour necrosis factor α and nuclear factor κB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide , 2003 .

[98]  T. Kirchner,et al.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. , 1992, Gastroenterology.

[99]  Luying Peng,et al.  Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier , 2007, Pediatric Research.

[100]  German and Austrian ImipenemCilastatin Study Group,et al.  Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial , 1996, Digestive Diseases and Sciences.

[101]  W. Koltun,et al.  Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. , 2007, The Journal of surgical research.

[102]  B. Trock,et al.  Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. , 1990, Journal of the National Cancer Institute.

[103]  A. Andoh,et al.  Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. , 1999, JPEN. Journal of parenteral and enteral nutrition.

[104]  T. Wolever,et al.  Acarbose raises serum butyrate in human subjects withimpaired glucose tolerance , 2000, British Journal of Nutrition.

[105]  T. Wolever,et al.  Serum acetate:propionate ratio is related to serum cholesterol in men but not women. , 1996, The Journal of nutrition.

[106]  T. Adrian,et al.  Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon. , 1991, Scandinavian journal of gastroenterology.

[107]  C. Knauf,et al.  Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. , 2006, Life sciences.

[108]  D. Topping,et al.  Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids , 2007, Cancer biology & therapy.

[109]  J. Cummings,et al.  The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis , 2000, Gut.

[110]  M. Gassull,et al.  Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis , 1999 .

[111]  B. Sands.  Inflammatory bowel disease: past, present, and future , 2007, Journal of Gastroenterology.

[112]  Y. Lacasse,et al.  From the authors , 2005, European Respiratory Journal.

[113]  M. Nyman,et al.  Short-chain fatty acid formation in the hindgut of rats fed oligosaccharides varying in monomeric composition, degree of polymerisation and solubility , 2005, British Journal of Nutrition.

[114]  M. Gassull,et al.  Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). , 1999, The American journal of gastroenterology.

[115]  S. Koyama,et al.  The dietary combination of germinated barley foodstuff plus Clostridium butyricum suppresses the dextran sulfate sodium-induced experimental colitis in rats. , 2000, Scandinavian journal of gastroenterology.

[116]  J. Baker,et al.  Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial , 1996, Alimentary pharmacology & therapeutics.

[117]  D. Berger.  Plasmin/Plasminogen System in Colorectal Cancer , 2002, World Journal of Surgery.

[118]  H. Lührs,et al.  Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers , 2006, British Journal of Nutrition.

[119]  T. Hibi,et al.  Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. , 2003, International journal of molecular medicine.

[120]  A. Andoh,et al.  Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. , 2004, International journal of molecular medicine.

[121]  N. Read,et al.  Physiological and Clinical Aspects of Short Chain Fatty Acids , 1996 .

[122]  S. Karaki,et al.  Expression of the short-chain fatty acid receptor, GPR43, in the human colon , 2008, Journal of Molecular Histology.

[123]  T. Miller,et al.  Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer. , 1988, Gut.

[124]  J. Chayvialle,et al.  Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon , 2000, Gut.

[125]  P. Gibson,et al.  Does butyrate protect from colorectal cancer? , 2006, Journal of gastroenterology and hepatology.

[126]  P. Rutgeerts,et al.  In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. , 1998, Gastroenterology.

[127]  Tatsuya Abe,et al.  The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. , 2007, Biochemical and biophysical research communications.

[128]  W. Verstraete,et al.  Inulin‐type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects , 2007, Journal of applied microbiology.

[129]  Hata,et al.  Counter‐regulatory effect of sodium butyrate on tumour necrosis factor‐alpha (TNF‐α)‐induced complement C3 and factor B biosynthesis in human intestinal epithelial cells , 1999, Clinical and experimental immunology.

[130]  Patrice D Cani,et al.  Oligofructose promotes satiety in healthy human: a pilot study , 2006, European Journal of Clinical Nutrition.

[131]  E. di Giulio,et al.  Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis , 2000, Digestive Diseases and Sciences.

[132]  H. Hayashi,et al.  Propionate absorption associated with bicarbonate secretion in vitro in the mouse cecum , 2007, Pflügers Archiv - European Journal of Physiology.

[133]  P. Calder,et al.  The immune system: a target for functional foods? , 2002, The British journal of nutrition.

[134]  F. D'armiento,et al.  Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. , 1994, Gastroenterology.

[135]  W. Roediger.  The starved colon—Diminished mucosal nutrition, diminished absorption, and colitis , 1990, Diseases of the colon and rectum.

[136]  Philippe Chavatte,et al.  PPARγ as a new therapeutic target in inflammatory bowel diseases , 2006, Gut.

[137]  H. Glatt,et al.  Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. , 2006, Carcinogenesis.

[138]  Patrice D Cani,et al.  Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. , 2005, Obesity research.

[139]  J. Davie.  Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.

[140]  Patrice D Cani,et al.  Impact of inulin and oligofructose on gastrointestinal peptides , 2005, British Journal of Nutrition.

[141]  J. Malago,et al.  Anti‐inflammatory properties of heat shock protein 70 and butyrate on Salmonella‐induced interleukin‐8 secretion in enterocyte‐like Caco‐2 cells , 2005, Clinical and experimental immunology.

[142]  A. Amorosi,et al.  Effects of short chain fatty acids on mucosal proliferation and inflammation of ileal pouches in patients with ulcerative colitis and familial polyposis , 1995, Diseases of the colon and rectum.

[143]  R. Sartor,et al.  The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. , 2000, American journal of physiology. Cell physiology.

[144]  R. Place,et al.  HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. , 2005, Biochemical pharmacology.

[145]  R. van der Meer,et al.  Dietary fructooligosaccharides increase intestinal permeability in rats. , 2005, The Journal of nutrition.

[146]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[147]  Luying Peng,et al.  Short-Chain Fatty Acids Induce Colonic Mucosal Injury in Rats with Various Postnatal Ages , 2005, Pediatric Research.

[148]  I. Björck,et al.  Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects , 2008, European Journal of Clinical Nutrition.

[149]  J. Lampe,et al.  Apparent fiber digestibility and fecal short-chain fatty acid concentrations with ingestion of two types of dietary fiber. , 1994, JPEN. Journal of parenteral and enteral nutrition.

[150]  M. Usami,et al.  Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. , 2005, Nutrition.

[151]  Yasuo Suzuki,et al.  Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation. , 2002, Biochemical and biophysical research communications.

[152]  G. Mazzacca,et al.  Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. , 1996, Gastroenterology.

[153]  G. Corrao,et al.  Short‐chain fatty acid topical treatment in distal ulcerative colitis , 1995, Alimentary pharmacology & therapeutics.

[154]  B. G. Wolthers,et al.  Volatile fatty acids in human peripheral and portal blood: quantitative determination vacuum distillation and gas chromatography. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[155]  M. Schwab,et al.  PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2. , 2006, Apoptosis : an international journal on programmed cell death.

[156]  C. Hallert,et al.  Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. , 1991, Scandinavian journal of gastroenterology.

[157]  P. Gibson,et al.  Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. , 1993, Gut.

[158]  C. Neut,et al.  Treatment of diversion colitis by short-chain fatty acids , 1991, Diseases of the colon and rectum.

[159]  A. Esterman,et al.  Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. , 2006, Carcinogenesis.

[160]  A. Basit,et al.  An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans. , 2006, Journal of pharmaceutical sciences.

[161]  K. Herzig,et al.  Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. , 2006, World journal of gastroenterology.

[162]  J. Dekker,et al.  Role of mucins in inflammatory bowel disease: important lessons from experimental models , 2002, European journal of gastroenterology & hepatology.

[163]  S. Riley,et al.  Butyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)? , 2006, Kidney international.

[164]  A. Lacic.  [A new look]. , 1989, Pielegniarka i polozna.

[165]  I. Macdonald,et al.  In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis , 2000, Gut.

[166]  K. Daly,et al.  Microarray analysis of butyrate regulated genes in colonic epithelial cells. , 2006, DNA and cell biology.

[167]  J. Galmiche,et al.  Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[168]  V. Annese,et al.  Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial , 2003, European journal of clinical investigation.

[169]  N. Langkilde,et al.  Short-chain fatty acids stimulate mucosal cell proliferation in the closed human rectum after Hartmann’s procedure , 1999, International Journal of Colorectal Disease.

[170]  S. Citi,et al.  Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. , 2004, Molecular cancer research : MCR.

[171]  S. Meng,et al.  Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[172]  K. Barrett.  A new twist on trefoils. Focus on "TFF3 modulates NF-{kappa}B and a novel regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}". , 2005, American journal of physiology. Cell physiology.

[173]  A. Eschalier,et al.  Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. , 2005, Gastroenterology.

[174]  J. Dekker,et al.  Enteral inulin does not affect epithelial gene expression and cell turnover within the ileoanal pouch , 2000, Diseases of the colon and rectum.

[175]  G. Corazza,et al.  Oral butyrate for mildly to moderately active Crohn's disease , 2005, Alimentary pharmacology & therapeutics.

[176]  B. Corfe,et al.  Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding , 2006, Oncogene.

[177]  M. Abdollahi,et al.  Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause? , 2007, Digestive Diseases and Sciences.

[178]  P. Marteau.  Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease? , 2006, Gut.

[179]  I. Finnie,et al.  Colonic mucin synthesis is increased by sodium butyrate. , 1995, Gut.

[180]  D. Tierney,et al.  Butyrate increases catalase activity and protects rat pulmonary artery smooth muscle cells against hyperoxia. , 1989, Biochemical and biophysical research communications.

[181]  B. Hinnebusch,et al.  The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. , 2002, The Journal of nutrition.

[182]  S. Krishnan,et al.  Stimulation of Sodium Chloride Absorption from Secreting Rat Colon by Short-Chain Fatty Acids , 1999, Digestive Diseases and Sciences.

[183]  J. Baron.  Dietary fiber and colorectal cancer: an ongoing saga. , 2005, JAMA.

[184]  M. Campieri,et al.  Rectal cell proliferation and colon cancer risk in ulcerative colitis. , 1990, Cancer research.

[185]  W. Scheppach,et al.  Effect of short-chain fatty acids on the human colonic mucosa in vitro. , 1992, JPEN. Journal of parenteral and enteral nutrition.

[186]  Butyrate and the Colonocyte , 1997 .

[187]  R. Sack,et al.  Amylase-resistant starch plus oral rehydration solution for cholera. , 2000, The New England journal of medicine.

[188]  A. Andoh,et al.  Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells , 2002, Cancer Immunology, Immunotherapy.

[189]  K. Ushida,et al.  Stimulation of butyrate production in the large intestine of weaning piglets by dietary fructooligosaccharides and its influence on the histological variables of the large intestinal mucosa. , 2003, Journal of nutritional science and vitaminology.

[190]  B. Brüne,et al.  Activation of PPARγ is not involved in butyrate-induced epithelial cell differentiation , 2005 .

[191]  M. Hegsted,et al.  Peptide YY and Proglucagon mRNA Expression Patterns and Regulation in the Gut , 2006, Obesity.

[192]  C. Cherbut.  Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract , 2003, Proceedings of the Nutrition Society.

[193]  Wilbert,et al.  Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. , 2003, Carcinogenesis.

[194]  R. Sartor,et al.  The IκB/NF-κB system: a key determinant of mucosal inflammation and protection , 2000 .

[195]  F. Mortensen,et al.  Short-chain fatty acid enemas stimulate plasminogen activator inhibitor-1 after abdominal aortic graft surgery: a double-blinded, placebo-controlled study. , 2000, Thrombosis research.

[196]  Andrew J. Wilson,et al.  Colonic epithelial cell activation and the paradoxical effects of butyrate. , 1999, Carcinogenesis.

[197]  L. Augenlicht,et al.  Inhibition of interferon γ signaling by the short chain fatty acid butyrate , 2003 .

[198]  A. Whittemore,et al.  Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. , 1992, Journal of the National Cancer Institute.

[199]  M. Lipkin,et al.  Proliferation and differentiation biomarkers in colorectal mucosa and their application to chemoprevention studies. , 1993, Environmental health perspectives.

[200]  J. Wehkamp,et al.  A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. , 2006, Annals of the New York Academy of Sciences.

[201]  E. Ho,et al.  Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? , 2006, Carcinogenesis.

[202]  U. Galderisi,et al.  Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis , 2005, Gut.

[203]  C. Plass,et al.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[204]  J. Mariadason,et al.  Effect of butyrate on paracellular permeability in rat distal colonic mucosa ex vivo , 1999, Journal of gastroenterology and hepatology.

[205]  W. Willett,et al.  Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. , 2005, JAMA.

[206]  W. James,et al.  Rectal absorption of short chain fatty acids in the absence of chloride. , 1979, Gut.

[207]  H. Ogata,et al.  Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. , 2008, International journal of medical microbiology : IJMM.

[208]  F. Mortensen,et al.  Microcirculatory and trophic effects of short chain fatty acids in the human rectum after Hartmann's procedure , 1991, The British journal of surgery.

[209]  R. Gallo,et al.  Control of the innate epithelial antimicrobial response is cell‐type specific and dependent on relevant microenvironmental stimuli , 2006, Immunology.

[210]  J. Saurin,et al.  Tumor Necrosis Factor &agr; Reduces Butyrate Oxidation In Vitro in Human Colonic Mucosa: A Link from Inflammatory Process to Mucosal Damage? , 2005, Inflammatory bowel diseases.

[211]  B. Lewis,et al.  Acarbose enhances human colonic butyrate production. , 1997, The Journal of nutrition.

[212]  Bandaru S. Reddy,et al.  Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies , 1998, British Journal of Nutrition.

[213]  M. Neuman.  Immune dysfunction in inflammatory bowel disease. , 2007, Translational research : the journal of laboratory and clinical medicine.

[214]  J. Stein,et al.  Rationale for the luminal provision of butyrate in intestinal diseases , 2000, European journal of nutrition.

[215]  E. Arrigoni,et al.  Human Faecal Microbiota Develops the Ability to Degrade Type 3 Resistant Starch During Weaning , 2006, Journal of pediatric gastroenterology and nutrition.

[216]  K. Ushida,et al.  Alteration of Gene Expression in the Colon of Colorectal Cancer Model Rat by Dietary Sodium Gluconate , 2006, Bioscience, biotechnology, and biochemistry.

[217]  H. Lührs,et al.  Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways , 2003, Gut.

[218]  S. Lewis,et al.  Increasing butyrate concentration in the distal colon by accelerating intestinal transit , 1997, Gut.

[219]  M. Gassull,et al.  Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis , 1999, American Journal of Gastroenterology.

[220]  N. Borruel,et al.  Oral oligofructose‐enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin , 2007, Alimentary pharmacology & therapeutics.

[221]  L. Cobiac,et al.  Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat , 2006, British Journal of Nutrition.

[222]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[223]  S. Shirazi-Beechey,et al.  The human colonic monocarboxylate transporter Isoform 1: its potential importance to colonic tissue homeostasis. , 2005, Gastroenterology.